These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 24029796)

  • 1. Patterns of initial antibiotic therapy for community-acquired pneumonia in U.S. hospitals, 2000 to 2009.
    Berger A; Edelsberg J; Oster G; Huang X; Weber DJ
    Am J Med Sci; 2014 May; 347(5):347-56. PubMed ID: 24029796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical resource utilization among community-acquired pneumonia patients initially treated with levofloxacin 750 mg daily versus ceftriaxone 1000 mg plus azithromycin 500 mg daily: a US-based study.
    Frei CR; Jaso TC; Mortensen EM; Restrepo MI; Raut MK; Oramasionwu CU; Ruiz AD; Makos BR; Ruiz JL; Attridge RT; Mody SH; Fisher A; Schein JR
    Curr Med Res Opin; 2009 Apr; 25(4):859-68. PubMed ID: 19231913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levofloxacin Versus Ceftriaxone and Azithromycin Combination in the Treatment of Community Acquired Pneumonia in Hospitalized Patients.
    Izadi M; Dadsetan B; Najafi Z; Jafari S; Mazaheri E; Dadras O; Heidari H; SeyedAlinaghi S; Voltarelli F
    Recent Pat Antiinfect Drug Discov; 2018; 13(3):228-239. PubMed ID: 30360748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Initial Route of Fluoroquinolone Administration and Outcomes in Patients Hospitalized for Community-acquired Pneumonia.
    Belforti RK; Lagu T; Haessler S; Lindenauer PK; Pekow PS; Priya A; Zilberberg MD; Skiest D; Higgins TL; Stefan MS; Rothberg MB
    Clin Infect Dis; 2016 Jul; 63(1):1-9. PubMed ID: 27048748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of the efficiency of antimicrobial treatment for community-acquired pneumonia in clinical practice].
    Zhukova OV; Ruina OV; Kononova SV; Konyshkina TM
    Ter Arkh; 2017; 89(8):17-21. PubMed ID: 28914846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial treatment failure in non-ICU community-acquired pneumonia: risk factors and association with length of stay, total hospital charges, and mortality.
    Oster G; Berger A; Edelsberg J; Weber DJ
    J Med Econ; 2013; 16(6):809-19. PubMed ID: 23574431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic utilization and cost analysis in hospitalized patients with community-acquired pneumonia.
    Stein GE; Mantz SL
    Hosp Pharm; 1995 Feb; 30(2):132-4, 137. PubMed ID: 10140526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Misdiagnosis of community-acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4-h antibiotic administration rule.
    Kanwar M; Brar N; Khatib R; Fakih MG
    Chest; 2007 Jun; 131(6):1865-9. PubMed ID: 17400668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
    Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS
    Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community-acquired pneumonia with risk for drug-resistant pathogens.
    Fleming V; Buck B; Nix N; Kumar P; Southwood R
    South Med J; 2013 Mar; 106(3):209-16. PubMed ID: 23462490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sputum bacteriology and antibiotic sensitivity patterns of community-acquired pneumonia in hospitalized adult patients in Nigeria: a 5-year multicentre retrospective study.
    Iroezindu MO; Chima EI; Isiguzo GC; Mbata GC; Onyedum CC; Onyedibe KI; Okoli LE
    Scand J Infect Dis; 2014 Dec; 46(12):875-87. PubMed ID: 25288384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azithromycin monotherapy for patients hospitalized with community-acquired pneumonia: a 31/2-year experience from a veterans affairs hospital.
    Feldman RB; Rhew DC; Wong JY; Charles RA; Goetz MB;
    Arch Intern Med; 2003 Jul; 163(14):1718-26. PubMed ID: 12885688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cost-minimization analysis comparing azithromycin-based and levofloxacin-based protocols for the treatment of patients hospitalized with community-acquired pneumonia: results from the CAP-IN trial.
    Samsa GP; Matchar DB; Harnett J; Wilson J
    Chest; 2005 Nov; 128(5):3246-54. PubMed ID: 16304269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute community-acquired pneumonia: current diagnosis and treatment.
    Bryan CS
    J S C Med Assoc; 2001 Jan; 97(1):19-26. PubMed ID: 11227252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targets for antibiotic and healthcare resource stewardship in inpatient community-acquired pneumonia: a comparison of management practices with National Guideline Recommendations.
    Jenkins TC; Stella SA; Cervantes L; Knepper BC; Sabel AL; Price CS; Shockley L; Hanley ME; Mehler PS; Burman WJ
    Infection; 2013 Feb; 41(1):135-44. PubMed ID: 23160837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and management of community-acquired pneumonia in adults.
    Watkins RR; Lemonovich TL
    Am Fam Physician; 2011 Jun; 83(11):1299-306. PubMed ID: 21661712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of health care-associated pneumonia empirically treated with guideline-concordant regimens versus community-acquired pneumonia guideline-concordant regimens for patients admitted to acute care wards from home.
    Chen JI; Slater LN; Kurdgelashvili G; Husain KO; Gentry CA
    Ann Pharmacother; 2013 Jan; 47(1):9-19. PubMed ID: 23324506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience.
    Micek ST; Kollef KE; Reichley RM; Roubinian N; Kollef MH
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3568-73. PubMed ID: 17682100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor outcomes of empiric ceftriaxone ± azithromycin for community-acquired pneumonia caused by methicillin-susceptible Staphylococcus aureus.
    So W; Crandon JL; Nicolau DP
    Intern Emerg Med; 2016 Jun; 11(4):545-51. PubMed ID: 26531307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
    Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
    Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.